docetaxel anhydrous has been researched along with cobalt in 3 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cobalt) | Trials (cobalt) | Recent Studies (post-2010) (cobalt) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 21,222 | 165 | 6,525 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Alshaker, H; Arafat, T; Böhler, T; Cooper, C; Kawano, Y; Pchejetski, D; Wang, Q; Winkler, M | 1 |
Patel, B; Patel, MM; Rawal, S | 1 |
Mandal, B; Mukherjee, B; Panda, J; Sarkar, R; Satapathy, BS; Sen, R; Tudu, B | 1 |
3 other study(ies) available for docetaxel anhydrous and cobalt
Article | Year |
---|---|
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cobalt; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Everolimus; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Inbred BALB C; Mice, Nude; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Signal Transduction; Taxoids; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Fabrication, optimisation and
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cobalt; Curcumin; Docetaxel; Drug Delivery Systems; Drug Screening Assays, Antitumor; Hemolysis; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Lipids; Lung Neoplasms; Microspheres; Nanostructures; Particle Size; Temperature; Tetrazolium Salts; Thiazoles; X-Ray Diffraction | 2020 |
Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Cobalt; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Ferric Compounds; Hemolysis; Humans; Magnetics; MCF-7 Cells; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; X-Ray Diffraction | 2021 |